|

ABL001 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Marlise Luskin, MD1

Indications

  • Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Ph+ ALL1
  • Chronic Myeloid Leukemia (CML) in Lymphoid Blast Crisis1
  • B-cell Acute Lymphoblastic Leukemia1
  • Cancer1

Chicago, Illinois1 trial

ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML

University of Chicago Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.